ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells.
about
PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic functionThe Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the KidneyUrsolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppressionAdaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation.Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.Losartan affects glomerular AKT and mTOR phosphorylation in an experimental model of type 1 diabetic nephropathy.Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling.Angiotensin II stimulates phosphorylation of an ectodomain-truncated platelet-derived growth factor receptor-beta and its binding to class IA PI3K in vascular smooth muscle cells.Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis.Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.mTORC1 Signaling Contributes to Drinking But Not Blood Pressure Responses to Brain Angiotensin II.Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway.The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway.Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2⁻/⁻ mice.ANG II enhances contractile responses via PI3-kinase p110 delta pathway in aortas from diabetic rats with systemic hyperinsulinemia.Kv1.3 channels modulate human vascular smooth muscle cells proliferation independently of mTOR signaling pathway.Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases
P2860
Q28578260-37BB521F-352D-4DC0-809B-0E47E0707CE6Q33983361-F873F1CD-D2DE-4216-B9C1-616BED4E6AA8Q35005356-3D554EEF-2611-4D38-8E6E-B008175D28EBQ35562829-02B135DF-39C9-4FA6-B9FD-FA1FE1E6D778Q35789287-5F6ADC08-6F9B-4E18-A978-D02D06D7B36CQ35924401-0B1F01D2-4755-4B9B-A166-A3374188ED9CQ37014674-94349665-87C2-40B9-B83C-E43A74648731Q37024574-93B7EE43-9AA7-4E73-BEEB-11A97F96D19BQ40262966-821578AA-1746-44CF-BDD7-D26792F174A2Q40299036-4757123E-D4AE-4E22-80A1-00B4229CC49EQ41819842-6132A517-4FEF-4ED2-924D-C5A90DEE6B1FQ42043023-9C30251F-DEEE-46A4-929E-6618992B2BD7Q42392476-CAA8DBD8-429A-4431-905B-9BA8E2F12436Q42725443-E460E69A-11AB-4CFD-BB5C-653CCEF1D1CEQ43211170-2BB4641D-9323-40A0-846C-E7F4266B0CF3Q46933191-4DADE89A-1D71-4BF4-ADC2-CE9916569AF4Q46976014-3932023E-323E-416A-9C10-92713DDFED89Q54323399-9DBECC42-49A5-4AC7-B3D7-9DEDFEA7F6D1Q57300947-2D46C486-2AEF-4041-9A68-855966A128E2
P2860
ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
ANG II activates effectors of ...... coronary smooth muscle cells.
@en
ANG II activates effectors of ...... coronary smooth muscle cells.
@nl
type
label
ANG II activates effectors of ...... coronary smooth muscle cells.
@en
ANG II activates effectors of ...... coronary smooth muscle cells.
@nl
prefLabel
ANG II activates effectors of ...... coronary smooth muscle cells.
@en
ANG II activates effectors of ...... coronary smooth muscle cells.
@nl
P2093
P2860
P1476
ANG II activates effectors of ...... coronary smooth muscle cells.
@en
P2093
Adrian H Chester
Magdi H Yacoub
Xuemin Wang
P2860
P304
P356
10.1152/AJPHEART.00040.2004
P577
2004-09-01T00:00:00Z